Literature DB >> 12109153

Is the widely used medicinal fungus the Ganoderma lucidum (Fr.) Karst. sensu stricto? (A short review).

Gyöngyi Szedlay1.   

Abstract

The identification of Ganoderma species is usually based on classical morphological criteria. The objectives of this review were to collect available information on Ganoderma lucidum and to utilize them in exact identification of Ganoderma lucidum (Fr.) Karst. sensu stricto. A lot of taxonomical confusion has always been associated with G. lucidum and allied species. Species circumscription, phylogenetic relationships, host range and distribution of species of the G. lucidum complex are unclear even among the few taxa living in temperate climate. Several methods have been proposed to identify the species as examination of cultural characteristics, isozymes, secondary metabolites, DNA sequences and interfertility. Although G. lucidum sensu stricto has been reported world-wide accumulated evidence supported the suggestion that it seems restricted to Europe. The strains used in the medicine are usually collected in Asia. There is little likelihood that any one belongs to the G. lucidum sensu stricto. The strains labelled as G. lucidum in the medicinal and pharmacological literature encompass a broad range of species which produce different medicinally active compounds and have significantly different pharmacological effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109153     DOI: 10.1556/AMicr.49.2002.2-3.9

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  3 in total

Review 1.  Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Authors:  Ulrike Grienke; Teresa Kaserer; Florian Pfluger; Christina E Mair; Thierry Langer; Daniela Schuster; Judith M Rollinger
Journal:  Phytochemistry       Date:  2014-11-06       Impact factor: 4.072

2.  Intraspecific Variation and Phylogenetic Relationships Are Revealed by ITS1 Secondary Structure Analysis and Single-Nucleotide Polymorphism in Ganoderma lucidum.

Authors:  Xiuqing Zhang; Zhangyang Xu; Haisheng Pei; Zhou Chen; Xiaoyan Tan; Jing Hu; Bin Yang; Junshe Sun
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

Review 3.  Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa.

Authors:  M A Oke; F J Afolabi; O O Oyeleke; T A Kilani; A R Adeosun; A A Olanbiwoninu; E A Adebayo
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.